Vishwajit Bhide has been appointed to the role of general manager at drug delivery device manufacturer Bespak, based in South Asia. Bhide will head Bespak's newly formed Asian liaison office, based in Mumbai, India, which will focus on offering support to key regional customers and carrying out market research in this fast developing arena.
Dr Oliver Haak has been appointed to the position of European technical sales manager for chemicals by Koch Membrane Systems. Based in the company's Duesseldorf office, his main brief is to support the chemicals business and build supply chain management across Europe.
Oxoid has appointed Phil Smith to lead its pharmaceutical marketing strategies and oversee and develop its growing business in the pharmaceutical sector. He will also be charged with ensuring that Oxoid products meet the changing needs of the pharmaceutical industry and the constraints imposed by regulatory restrictions.
Thermo Electron Corporation has named David Champagne as its new vice president and general manager of its informatics business. Champagne's career includes 13 years at Lotus Development Corporation and two roles as ceo for early-stage software companies. He joined Thermo in April 2003 as director of global services for informatics and later was promoted to divisional commercial director.
Gastrotech Pharma has appointed Dr Tina Nielsen as its new chief medical officer, where she will take up the responsibility for the management of Gastrotech's r&d activities. She has served as the company's clinical project manager since October 2004, and has 12 years of clinical experience at leading academic medical centres.
Punch and die manufacturer I Holland has appointed Janette Handley to the position of senior sales manager. She brings more than 20 years' experience in sales and marketing to the role, having worked in a variety of areas within the pharmaceutical and biotechnology industries, including manufacturing, secondary screening, HTS and QC.
Arena Pharmaceuticals has appointed Louis J. Lavigne, Jr, executive vice president and cfo of Genentech, to its board of directors. Lavigne adds depth and expertise to Arena's board. 'His leadership will be a valuable addition as we continue to build our pipeline,' said ceo Jack Lief.